MLYS in the 13F filings
Mineralys Therapeutics Inc · CUSIP 603170101
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 10 Feb 2026
- Managers listing it
- 26
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 4 listed it in both
- Shares listed
- 17,020,942
- combined, among listed positions
- Reported value
- $618m
- combined, at the quarter end
Among the 92 comparable managers: 20 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +4,795,084.
Managers listing MLYS in Q4 2025
26 of 26 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 5,057,509 shares now+2,986,254
- T. Rowe Price Associates Incexisting position · 1,325,120 shares now+1,303,737
- Janus Henderson Group Ltdexisting position · 1,213,265 shares now+1,193,417
- Two Sigma Investments LPnew position · 610,403 shares now+610,403
- D. E. Shaw & Co.existing position · 1,150,670 shares now+539,747
Reductions
- Citadel Advisors LLCexisting position · 399,919 shares now-1,667,308
- Farallon Capital Management LLCexisting position · 823,296 shares now-849,757
- Point72 Asset Management LPexisting position · 1,207,220 shares now-592,408
- Millennium Management LLCexisting position · 78,625 shares now-325,964
- Invesco Ltdexisting position · 29,141 shares now-158,845
New positions and exits
New (7)
Exited (5)
- Hudson Bay Capital Management LPwas $2.9m
- Jane Street Group LLCwas $1.4m
- Balyasny Asset Management LLCwas $579k
- ExodusPoint Capital Management LPwas $253k
- Quantbot Technologies LPwas $1k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2023 | 1 | $2.7m | n.a. | n.a. |
| Q2 2023 | 1 | $3.0m | n.a. | n.a. |
| Q3 2023 | 1 | $1.7m | n.a. | n.a. |
| Q4 2023 | 1 | $1.5m | 0 | 0 |
| Q3 2025 | 4 | $184m | 4 | 0 |
| Q4 2025 | 8 | $198m | 20 | 11 |
| Q1 2026 | 2 | $54m | 14 | 13 |
| Q2 2026 | 3 | $78m | 15 | 10 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
MLYS and LLY →MLYS and JNJ →MLYS and VRTX →Choose a stock to compare with MLYS →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own MLYS, latest filings →Back to the 13F Explorer →